Your browser doesn't support javascript.
loading
Preserved High Probability of Overall Survival with Significant Reduction of Chemotherapy for Myeloid Leukemia in Down Syndrome: A Nationwide Prospective Study in Japan.
Taga, Takashi; Watanabe, Tomoyuki; Tomizawa, Daisuke; Kudo, Kazuko; Terui, Kiminori; Moritake, Hiroshi; Kinoshita, Akitoshi; Iwamoto, Shotaro; Nakayama, Hideki; Takahashi, Hiroyuki; Shimada, Akira; Taki, Tomohiko; Toki, Tsutomu; Ito, Etsuro; Goto, Hiroaki; Koh, Katsuyoshi; Saito, Akiko M; Horibe, Keizo; Nakahata, Tatsutoshi; Tawa, Akio; Adachi, Souichi.
Afiliação
  • Taga T; Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan.
  • Watanabe T; Department of Nutritional Science, Faculty of Psychological and Physical Science, Aichi Gakuin University, Nisshin, Japan.
  • Tomizawa D; Division of Leukemia and Lymphoma, Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
  • Kudo K; Department of Pediatrics, Fujita Health University, Toyoake, Japan.
  • Terui K; Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
  • Moritake H; Division of Pediatrics, Department of Reproductive and Developmental Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
  • Kinoshita A; Department of Pediatrics, St. Marianna University School of Medicine, Kawasaki, Japan.
  • Iwamoto S; Department of Pediatrics, Mie University Graduate School of Medicine, Tsu, Japan.
  • Nakayama H; Department of Pediatrics, National Hospital Organization, Fukuoka-Higashi Medical Center, Fukuoka, Japan.
  • Takahashi H; Department of Pediatrics, Toho University, Tokyo, Japan.
  • Shimada A; Department of Pediatrics, Okayama University Hospital, Okayama, Japan.
  • Taki T; Department of Molecular Diagnostics and Therapeutics, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Toki T; Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
  • Ito E; Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
  • Goto H; Division of Hemato-Oncology and Regenerative Medicine, Kanagawa Children's Medical Center, Yokohama, Japan.
  • Koh K; Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.
  • Saito AM; Laboratory of Clinical, Epidemiological and Health Services Research, Clinical Research Center, National Hospital Organization, Nagoya Medical Center, Aichi, Japan.
  • Horibe K; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Nakahata T; Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
  • Tawa A; Department of Pediatrics, National Hospital Organization, Osaka Medical Center, Osaka, Japan.
  • Adachi S; Human Health Sciences, Kyoto University, Kyoto, Japan.
Pediatr Blood Cancer ; 63(2): 248-54, 2016 Feb.
Article em En | MEDLINE | ID: mdl-26481183
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Leucemia Mieloide / Síndrome de Down Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male País/Região como assunto: Asia Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Leucemia Mieloide / Síndrome de Down Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male País/Região como assunto: Asia Idioma: En Ano de publicação: 2016 Tipo de documento: Article